Amneal launches PEMRYDI RTU, ready-to-use version of pemetrexed, oncology injectable medicine Read more
Allecra’s EXBLIFEP approval to treat cUTIs provides valuable new weapon to tackle ESBL mediated AMR: GlobalData Read more